Foamix于2003年1月19号在以色列成立。该公司是一家临床阶段制药公司专注于开发和商业化公司专有的泡沫米诺环素治疗痤疮,脓疱疮等皮肤状况。该公司的主导候选产品,fmx101为中度至重...查看全文
牛唐2018-07-28 22:07
$Foamix(FOMX)$ FMX101是外用的minocyline,用于治疗痤疮,预计今年下半年或明年上半年申报NDA,如果获批的话,将是首个获批的米诺环素外用药查看全文
$Foamix(FOMX)$ 内部交易: 2018-01-03,Observer to the Board,Eini Meir ,卖出,5000普通股, $6.26
$Foamix(FOMX)$ 内部交易: 2018-01-02,Observer to the Board,Eini Meir ,卖出,5000普通股, $6.18
$Foamix(FOMX)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001178913-18-000059 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Foamix(FOMX)$ 8-K - Current report Filed: 2018-01-04 AccNo: 0001178913-18-000021 Size: 51 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Foamix(FOMX)$ 8-K - Current report Filed: 2018-01-03 AccNo: 0001178913-18-000011 Size: 47 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Other EventsItem...
$Foamix(FOMX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-12-19 AccNo: 0001178913-17-003428 Size: 367 KB 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-11-28 AccNo: 0001178913-17-003272 Size: 14 KB 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-11-14 AccNo: 0001178913-17-003152 Size: 392 KB 网页链接
$Foamix(FOMX)$ 美东时间 2017-11-14 盘后 披露财报,预期EPS -0.44 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-10-23 AccNo: 0001178913-17-002857 Size: 252 KB 网页链接